CLAIM #11983 · Bristol-Myers Squibb Company (BMY) · 2024Q2 earnings call · Jul 26, 2024 · due Jan 31, 2025
“We recognize this is a highly competitive market and we're continuing to make improvements and we expect further improvements in access in January.”
Adam Lenkowsky · Chief Commercialization Officer
PENDING
graded after results covering Jan 31, 2025 are reported
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2024Q2 earnings call.